|
Market Closed -
Euronext Paris
20:55:00 27/10/2026 +04
|
After hours 23:15:17 | |||
| 85.48 EUR | -0.58% |
|
85.55 | +0.08% |
| 10-26 | Eurofins Scientific, Heading for a Sixth Consecutive Gain |  |
| 10-21 | Eurofins Scientific: Inevitable organic guidance downgrade arrives despite BioPharma showing signs of improvement |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 16.69B | |||||
| 65.28B | |||||
| 54.57B | |||||
| 53.59B | |||||
| 45.03B | |||||
| 42.17B |
- Stock Market
- Stocks
- ERF Stock
- Charts Eurofins Scientific SE
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
